NCT06953882
- Conditions
- HER2 Negative Breast Cancer
- Locations
-
- Yale University New Haven, Connecticut, United States
Clinical trial condition
HER2 Negative Breast Cancer
Explore clinical trials studying HER2 Negative Breast Cancer. Study availability and eligibility vary by location and protocol.
6 public trials
2 recruiting studies
HER2 Negative Breast Cancer trial results
NCT06731140
- Conditions
- HER2 Negative Breast Cancer
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Shared Decision Making for Patients With HER2-negative Metastatic Breast Cancer (SDM-01)
NCT07578415
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
Not specified
NCT01840306
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +6 more
- Locations
-
- Bon Secours Hospital Cork, Ireland
- Cork University Hospital Cork, Ireland
- Letterkenny General Hospital Donegal, Ireland
- Our Lady of Lourdes Hospital Drogheda, Ireland
NCT01527487
- Conditions
- Breast Diseases, Breast Neoplasms, HER2 Negative Breast Cancer, +4 more
- Locations
-
- Florida Cancer Specialists South Fort Myers, Florida, United States
- Memorial Cancer Institute Hollywood, Florida, United States
- Woodlands Medical Specialists Pensacola, Florida, United States
- Florida Cancer Specialists North St. Petersburg, Florida, United States
Active, Not Recruiting
Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging
NCT03568448
- Conditions
- HER2 Negative Breast Cancer
- Locations
-
- University of New Mexico Comprehensive Cancer Center Albuquerque, New Mexico, United States